Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-20T18:22:56.582Z Has data issue: false hasContentIssue false
  • English
  • Français

Nutrition and HIV infection

Published online by Cambridge University Press:  09 March 2007

J. Salomon ,
P. De Truchis  and
J.-C. Melchior
J. Salomon*
Affiliation:
Department of Infectious Diseases and Internal Medicine, Raymond Poincaré University Hospital, 104 Boulevard Raymond Poincaré, 92 380 Garches, France
P. De Truchis
Affiliation:
Department of Infectious Diseases and Internal Medicine, Raymond Poincaré University Hospital, 104 Boulevard Raymond Poincaré, 92 380 Garches, France
J.-C. Melchior
Affiliation:
Department of Infectious Diseases and Internal Medicine, Raymond Poincaré University Hospital, 104 Boulevard Raymond Poincaré, 92 380 Garches, France
*
*Corresponding author: Dr J. Salomon, fax +33 1 47 10 77 67, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Article
Information
British Journal of Nutrition , Volume 87 , Issue S1 , January 2002 , pp. S111 - S119
Copyright
Copyright © The Nutrition Society 2002

References

Babl, FE, Regan, AM & Pelton, SI (1999) Abnormal body-fat distribution in HIV-1 infected children on antiretrovirals. Lancet 353, 1243–1244.CrossRefGoogle ScholarPubMed
Batterham, MJ, Garsia, R & Greenop, P (1999) Measurement of body composition in people with HIV/AIDS: a comparison of bioelectrical impedance and skinfold anthropometry with dual-energy x-ray absorptiometry. Journal of American Dietetic Association 99, 1109–1111.CrossRefGoogle ScholarPubMed
Baum, MK, Shor-Posner, G & Lai, S (1997) High-risk of HIV-related mortality is associated with selenium deficiency. Journal of Acquired Immunodeficiency and Human Retrovirology 5, 370–374.CrossRefGoogle Scholar
Baum, MKet al. (1998) Micronutrient status in relationship to mortality in HIV-1 disease. Nutrition Reviews 56, S135–S139.CrossRefGoogle ScholarPubMed
Baumgartner, RN, Chumlea, WC & Roche, AF (1989) Estimation of body composition for bioelectric impedance of body segments. American Journal of Clinical Nutrition 50, 221–226.CrossRefGoogle ScholarPubMed
Behrens, G, Schmidt, H & Meyer, D (1998) Vascular complications associated with use of HIV protease inhibitors. Lancet 351, 1958.CrossRefGoogle ScholarPubMed
Behrens, G, Dejam, A, Schmidt, H, Belks, HJ, Brabnt, G, Korner, T, Stoll, M & Schmidt, RE (1999) Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS 13, 63–70.CrossRefGoogle ScholarPubMed
Bell, PM & Hadden, DR (1997) Metformin. Endocrinology and Metabolism Clinics of North America 26, 523–537.CrossRefGoogle ScholarPubMed
Berger, B, Ollenschlager, G, Schrappe, M, Stute, A, Fischer, M, Wessel, D, Schwenk, A & Diehl, V (1993) Nutrition behavior of malnourished HIV-infected patients and intensified oral nutritional intervention. Nutrition 9, 43–44.Google Scholar
Berger, J, Pall, L, Hall, C, Simpson, D, Berry, P & Dudley, R (1996) Oxandrolone in AIDS-wasting myopathy. AIDS 10, 1657–1662.CrossRefGoogle ScholarPubMed
Bhasin, S, Storer, T, Asbel-Sethi, N (1998) Effects of testosterone replacement with a nongenital transdermal system, androderm, in human immunodeficiency virus-infected men with low testosterone levels. Journal of Clinical Endocrinology and Metabolism 83, 3155–3162.Google ScholarPubMed
Bhasin, S, Storer, T & Javanbakht, M (2000) Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. Journal of the American Medical Association 283, 763–770.CrossRefGoogle ScholarPubMed
Blanche, S, Tardieu, M, Rustin, P, Slama, A, Barret, B, Firtion, G, Ciraru-Vigneron, N, Lacroix, C, Rouzioux, N, Mandelbrot, L, Desguerre, I, Rötig, A, Mayaux, MJ & Delfraissy, JF (1999) Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 354, 1084–1089.CrossRefGoogle ScholarPubMed
Bonnet, E, Lepec, R & Bluteau, M (2000) A prospective, open-label pilot trial of a maintenance nevirapine-containing regimen in patients with undectectable viral loads on protease inhibitor regimens for at least 6 months. In Seventh Conference on retroviruses and Opportunistic Infections. San Francisco, CA.Google Scholar
Brinkman, K, Smeitink, JA, Romijn, JA & Reiss, P (1999) Mitochondrial toxicity induced by nucleoside analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral therapy related lipodystrophy. Lancet 354, 1112–1115.CrossRefGoogle ScholarPubMed
Carbonnel, F, Maslo, C & Beaugerie, L (1998) Effect of indinavir on HIV-related wasting. AIDS 12, 1777–1784.CrossRefGoogle ScholarPubMed
Carr, A, Samaras, K, Chisholm, DJ & Cooper, DA (1998a) Pathogenesis of HIV-1 protease inhibitor associated peripheral lipodystrophy, hyperlipidemia and insulin resistance. Lancet 351, 1881–1883.CrossRefGoogle ScholarPubMed
Carr, A, Samaras, K, Burton, S, Law, M, Freund, J, Chrisholm, D & Cooper, DA (1998b) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance due to HIV protease inhibitors. AIDS 12, 51–58.CrossRefGoogle ScholarPubMed
Carr, A, Samaras, K, Thorisdottir, A, Kaufmann, GR, Chrisholm, DJ & Cooper, DA (1999) Diagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidemia and diabetes mellitus: a cohort study. Lancet 353, 2093–2099.CrossRefGoogle ScholarPubMed
Carr, A, Miller, J, Law, M & Cooper, DA (2000) A syndrome of lipoatrophy, lactic acidemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 14, 25–32.CrossRefGoogle ScholarPubMed
CDC (1987) Revised classification system for HIV infections and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report 36, 1–15s.Google Scholar
CDC (1993) Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report 41, 1–19.Google Scholar
Danner, SA, Carr, A & Leonard, JM (1995) A short-term study of the safety, pharmacokinetics and efficacy of ritonavir, an inhibitor of HIV-1 protease. The New England Journal of Medicine 333, 1528–1533.CrossRefGoogle ScholarPubMed
Dowling, S, Mulcahy, F & Gibney, M (1990) Nutrition in the management of HIV antibody positive patients: a longitudinal study of dietetic out-patient advice. European Journal of Clinical Nutrition 44, 823–829.Google ScholarPubMed
Dubé, MP, Johnson, DL & Currier, JS (1997) Protease inhibitor-associated hyperglycemia. Lancet 350, 713–714.CrossRefGoogle Scholar
Ellis, KJ & Bell, SJ (1999) Bioelectrical impedance methods in clinical research: a follow-up to the NIH Technology Assessment Conference. Nutrition 15, 874–880.CrossRefGoogle Scholar
Gallet, B, Pullik, M & Genet, P (1998) Vascular complications associated with use of HIV protease inhibitors. Lancet 351, 1958–1959.CrossRefGoogle ScholarPubMed
Garg, A & Grundy, SM (1990) Nicotinic acid as therapy for dyslipidemia in non-insulin dependent diabetes mellitus. Journal of the American Medical Association 264, 723–726.CrossRefGoogle ScholarPubMed
Garg, A (1998) Dyslipoproteinemia and diabetes. Endocrinology and Metabolism Clinics of North America 27, 613–625.CrossRefGoogle ScholarPubMed
Gharakanian, S, Salhi, Y & Adda, N (2000). Identification of fat redistribution metabolic anomalies in a cohort treated by 2 NRTIs + 1 PI and absence of significant modification following PI substitution. In Seventh Conference on Retroviruses and Opportunistic Infections. San Francisco, CA.Google Scholar
Gibson, RS et al. (1990) Principles of Nutritional Assessment, New York, NY: Oxford University Press.Google Scholar
Goebel, F & Walli, RK (2000) A novel use of abacavir to simplify therapy in PI experienced patients successfully treated with HAART: CNA30017. In Seventh Conference on Retroviruses and Opportunistic Infections. San Francisco, CA.Google Scholar
Goujard, C, Lascaux, AS, Dulioust, A, Boué, F, Delfraissy, JF, Sobel, A & Boufassa, F. (2000) Lipodystrophy in PI-naive patients treated with RTI combinations: frequency and risk factors. In: Seventh Conference on Retroviruses and Opportunistic Infections. San Francisco, CA.Google Scholar
Grinspoon, S, Corcoran, C & Miller, K (1997) Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. Journal of Clinical Endocrinology and Metabolism 82, 1332–1337.Google ScholarPubMed
Grinspoon, S, Corcoran, C & Askari, H (1998) Effects of androgen administration in men with AIDS wasting: a randomized, placebo-controlled trial. Annals of Internal Medicine 129, 18–26.CrossRefGoogle Scholar
Grinspoon, S, Corcoran, C & Rosenthal, D (1999) Quantitative assessment of cross-sectional muscle area, functional status and strength in men with the AIDS wasting syndrome. Journal of Clinical Endocrinology and Metabolism 84, 201–206.Google Scholar
Grunfeld, C, Kotler, DP & Shigenaga, JK (1991) Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. American Journal of Medicine 90, 154–162.CrossRefGoogle ScholarPubMed
Grunfeld, C, Pang, M & Shimizu, L (1992a) Resting energy expenditure, caloric intake and weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. American Journal of Clinical Nutrition 55, 455.CrossRefGoogle ScholarPubMed
Grunfeld, C, Pang, M & Doerrler, W (1992b) Lipids, lipoproteins, triglyceride clearance and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Journal of Clinical Endocrinology and Metabolism 74, 1045–1052.Google ScholarPubMed
Guenter, P, Muurahainen, N & Simons, G (1993) Relationships among nutritional status, disease progression and survival in HIV infection. Journal of Acquired ImmunoDeficiency Syndrome 6, 1130.Google ScholarPubMed
Hadigan, C, Corcoran, C, Stanley, T, Piecuch, S, Klibanski, A & Grinspoon, S (2000a) Fasting hyperinsulinemia in HIV-infected men: relationship to body composition, gonadal function and protease-inhibitor use. Journal of Clinical Endocrinology and Metabolism 85, 35–41.Google ScholarPubMed
Hadigan, C, Miller, K, Corcoran, C, Anderson, E, Basgoz, N & Grinspoon, S (1999) Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. Journal of Clinical Endocrinology and Metabolism 84, 1932–1937.Google ScholarPubMed
Hadigan, C, Corcoran, C & Basgoz, N (2000b) Metformin in the treatment of HIV lipodystrophy syndrome. Journal of the American Medical Association 284, 472–477.Google ScholarPubMed
Haffner, SM & Miettinen, H (1997) Insulin resistance implications for type II diabetes mellitus and coronary heart disease. American Journal of Medicine 103, 152–162.CrossRefGoogle ScholarPubMed
Hellerstein, MC, Grunfeld, C & Wu, F (1993) Increased de novo lipogenesis in human immunodeficiency virus infection. Journal of Clinical Endocrinology and Metabolism 7, 559.Google Scholar
Henry, K, Melroe, H & Huebsch, J (1998a) Severe premature coronary artery disease with protease inhibitors. Lancet 351, 1328.CrossRefGoogle ScholarPubMed
Henry, K, Melroe, H & Huebsch, J (1998b) Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Lancet 352, 1031–1032.CrossRefGoogle ScholarPubMed
Hokanson, JE & Austin, MA (1996) Plamas triglyceride level is a risk factor for cardiovascular disease independent of HDL cholesterol level: a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk 3, 213–219.CrossRefGoogle Scholar
Hommes, MJT, Romijn, JA, Endert, E, Eeftinck-Schattenkenkerk, JKM & Sauerwein, HP (1991) Insulin sensitivity and insulin clearance in human immunodeficiency virus infected men. Metabolism 40, 651.CrossRefGoogle ScholarPubMed
Ireton-Jones, CS et al. (1998) Evaluation of outcomes for patients with AIDS receiving home total parenteral nutrition. Nutrition 14, 731–735.CrossRefGoogle ScholarPubMed
Kotler, DP, Wang, J & Pierson, R (1985) Studies of body composition in patients with acquired immunodeficiency syndrome. American Journal of Clinical Nutrition 42, 1255–1265.CrossRefGoogle ScholarPubMed
Kotler, DP, Tierney, AR, Wang, J & Pierson, RE (1989) Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. American Journal of Clinical Nutrition 50, 444–447.CrossRefGoogle ScholarPubMed
Kotler, D, Tierney, AR & Ferraro, R (1991) Enteral alimentation and repletion of body cell mass in malnourished patients with acquired immunodeficiency syndrome. American Journal of Clinical Nutrition 53, 149.CrossRefGoogle ScholarPubMed
Lo, JC, Mulligan, K, Tai, VW, Algren, H & Schambelan, M (1998) Buffalo hump in men with HIV 1 infection. Lancet 351, 867–870.CrossRefGoogle ScholarPubMed
Lukaski, HC, Bolonchuk, WW, Hall, CB & Siders, WA (1986) Validation of tetra polar bioelectrical impedance method to assess human body composition. Journal of Applied Physiology 60, 1327–1332.CrossRefGoogle Scholar
Lumpkin, MM (1997) Reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treament of human immunodeficiency virus (HIV). FDA Public Health Advisory.Google Scholar
Macallan, DC, Noble, C & Baldwin, C (1993) Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. American Journal of Clinical Nutrition 58, 417.CrossRefGoogle ScholarPubMed
Macallan, DC, Noble, C & Baldwin, C (1995) Energy expenditure and wasting in human imunodeficiency virus infection. New England Journal of Medicine 333, 83–88.CrossRefGoogle Scholar
Madge, S, Kinloch-de-Loes, S, Mercey, D, Johnson, MA & Weller, IVD (1999) Lipodystrophy in patients naive to HIV protease inhibitors. AIDS 13, 735–737.CrossRefGoogle ScholarPubMed
Martinez, E, Conget, I & Lozano, L (1999) Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine. AIDS 13, 805–810.CrossRefGoogle ScholarPubMed
Melchior, JC, Raguin, G & Boulier, A (1993) Resting energy expenditure in HIV infected patients. Comparison between patients with and without secondary infections. American Journal of Clinical Nutrition 57, 614.CrossRefGoogle ScholarPubMed
Melchior, JC, Chastang, C & Gelas, P (1996) Efficacy of 2 month total parenteral nutrition in AIDS patients: a controlled randomized prospective trial. AIDS 10, 379–384.CrossRefGoogle ScholarPubMed
Melchior, JC, Gelas, P, Carbonnel, F & Zazzo, JF (1998) Improved survival by home total parenteral nutrition in AIDS patients: follow-up of a controlled randomized prospective trial. AIDS 12, 336–337.Google ScholarPubMed
Melchior, JC, Niyongabo, T & Henzel, D (1999) Malnutrition and wasting, immunodepression, and chronic inflammation as independant predictors of survival in HIV-infected patients. Nutrition 15, 865–869.CrossRefGoogle Scholar
Mhiri, C, Belec, L, DiCostanza, B, Georges, A & Gherardi, R (1992) The slim disease in African patients with AIDS. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 303–306.CrossRefGoogle ScholarPubMed
Miller, KD, Jones, E & Yanovski, JA (1998) Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 351, 871–875.CrossRefGoogle ScholarPubMed
Mizock, BA & Falk, JL (1992) Lactic acidosis in critical illness. Critical Care Medicine 20, 80–93.CrossRefGoogle ScholarPubMed
Mulligan, K, Grunfeld, C, Hellerstein, M, Neese, RA & Schambelan, M (1993) Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immuodeficiency virus infection. Journal of Clinical Endocrinology and Metabolism 77, 956–962.Google Scholar
Mulligan, K, Grunfeld, C, Tai, VW, Algren, H, Pang, M, Chernoff, DN & Schambelan, M (2000) Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. Journal of Acquired Immunodeficiency Syndrome 23, 35–43.CrossRefGoogle ScholarPubMed
Nahlen, BL, Chu, SY, Nwanyanwu, OC, Berkelman, RL, Martinez, SA & Rullan, JV (1993) HIV wasting syndrome in the United States. AIDS 7, 183.CrossRefGoogle ScholarPubMed
Niyongabo, T, Melchior, JC, Henzel, D, Bouchard, O & Larouze, B (1999) Comparison of methods for assessing nutritional status in HIV-infected adults. Nutrition 15, 740–743.CrossRefGoogle ScholarPubMed
Ockenga, J, Süttmann, U & Selberg, O (1996) Percutaneous endoscopic gastrostomy in AIDS and control patients: risks and outcomes. American Journal Gastroenterology 91, 1817–1822.Google Scholar
Opravil, M, Yerly, S & Lazzarin, A (2000) Protease inhibitor class-sparing maintenance therapy with abacavir + lamivudine + zidovudine in patients with long-term suppression of HIV-1 RNA. In Seventh Conference on Retroviruses and Opportunistic Infections. San Francisco, CA.Google Scholar
Oster, M, Enders, S & Samuels, S (1994) Megestrol acetate in patients with AIDS and cachexia. Annals of Internal Medicine 121, 400–408.CrossRefGoogle ScholarPubMed
Ott, M, Lembcke, B & Fisher, H (1993) Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. American Journal of Clinical Nutrition 57, 15.CrossRefGoogle ScholarPubMed
Paton, NI, Castello-Branco, LR (1999) Impact of tuberculosis on the body composition of HIV-infected men in Brazil. Journal of Acquired Immunodeficiency Syndrome 20, 265–271.Google ScholarPubMed
Paton, N, Newton, PJ & Sharpstone, D (1999) Short-term growth hormone administration at the time of opportunistic infections in HIV-positive people. AIDS 13, 1995–2002.CrossRefGoogle Scholar
Periard, D, Telenti, A & Sudre, P (1999) Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation 100, 700–705.CrossRefGoogle ScholarPubMed
Perlenicek, JP, Graham, NM & He, YD (1996) Weight loss prior to clinical AIDS as predictor of survival. Multicenter AIDS cohort Study Investigators. Journal of Acquired Immunodeficiency Syndrome 10, 366.Google Scholar
Purnell, JQ, Zambon, A & Knopp, H (2000) Effects of ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS 14, 51–57.CrossRefGoogle ScholarPubMed
Roubenoff, R, McDermott, A, Weiss, L, Heflin, T, Cloutier, GJ, Wood, M & Gorbach, S (1999) Short-term progressive resistance training increases strenght and lean body mass in adults infected with human immunodeficiency virus. AIDS 13, 231–239.CrossRefGoogle Scholar
Rozenbaum, W, Molina, JM & Delfraissy, JF (2000) Improvment of lipodystrophy in HIV-1 infected subjects switching from 2 NRTI/PI to 2NRTI/Abacavir (French substudy, CNA30017). In Seventh Conference on Retroviruses and Opportunistic Infections. San Francisco, CA.Google Scholar
Ruiz, L, Negredo, E & Domingo, P (2000) Clinical, virological and immunological benefit of switching the protease inhibitor by nevirapine in HAART-experienced patients suffering lipodystrophy: 36-week follow-up. In Seventh Conference on Retroviruses and Opportunistic Infections. San Francisco, CA.Google Scholar
Saint-Marc, T, Partisani, M, Poizot-Martin, I, Rouvière, O, Bruno, F, Avallaneda, R, Lang, JM, Gastaut, JA & Touraine, JL (1999) A syndrome of peripheral fat wasting in patients receiving long-term nucleoside analogue therapy. AIDS 13, 1659–1667.CrossRefGoogle ScholarPubMed
Safrin, S & Grunfeld, C (1999) Fat distribution and metabolic changes in patients with HIV infection. AIDS 13, 2493–2505.CrossRefGoogle ScholarPubMed
Schambelan, M, Mulligan, K & Grunfeld, C (1996) Recombinant human growth hormone in patients with HUV-associated wasting. Annals of Internal Medicine 125, 873–882.CrossRefGoogle ScholarPubMed
Serwadda, D, Mugerwa, R & Sewanfambo, N (1985) Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 2, 849–852.CrossRefGoogle ScholarPubMed
Shabert, J, Winslow, C, Lacey, J & Wilmore, D (1999) Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized double-blind controlled trial. Nutrition 15, 860–864.CrossRefGoogle ScholarPubMed
Silva, M, Skolnik, P & Gorbach, S (1998) The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 12, 1645–1651.CrossRefGoogle ScholarPubMed
Strawford, A, Barbieri, T & Neese, R (1999) Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss. Journal of Acquired ImmnunoDeficiency Syndrome and Human Retrovirology 20, 137–146.CrossRefGoogle ScholarPubMed
Sullivan, AK & Nelson, MR (1997) Marked hyperlipidaemia in ritonavir therapy. AIDS 11, 938–939.Google ScholarPubMed
Süttmann, U, Ockenga, J & Selberg, O (1995) Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. Journal of Acquired Immunodeficiency Syndrome 8, 239.Google ScholarPubMed
Tebas, P, Yarasheski, K & Powderly, WG (2000) A prospective open-label pilot trial of a maintenance nevirapine-containing regimen in patients with undetectable viral loads on protease inhibitor regimens for at least 6 months. In Seventh Conference on Retroviruses and Opportunistic Infections. San Francisco, CA.Google Scholar
Vittecoq, D, Escaut, L & Monsuez, JJ (1998) Vascular complications associated with use of HIV protease inhibitors. Lancet 351, 1959.CrossRefGoogle ScholarPubMed
Von Roenn, J, Amstrong, D & Kotler, D (1994) Megestrol acetate in patients with AIDS-related cachexia. Annals of Internal Medicine 121, 393–399.CrossRefGoogle ScholarPubMed
Walli, R, Herfort, O, Michl, GM, Demant, T, Jager, H, Dieterle, C, Bogner, , Landgraf, R & Goebel, FD (1998) Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1 infected patients. AIDS 12, 167–173.CrossRefGoogle ScholarPubMed
Wanke, C, Silva, M, Knox, T, Forrester, J, Speigelman, D & Gorbach, S (2000) Weight loss and wasting remain common complications in individuals infected with HIV in the era of highly active antiretroviral therapy. Clinical Infectious Diseases 31, 803–805.CrossRefGoogle ScholarPubMed
Wheeler, DA, Givert, CL & Launer, CA (1998) Weight loss as a predictor of survival and disease progression in HIV infection. Journal of Acquired Immunodeficiency Syndrome and Human Retrovirology 18, 80–85.CrossRefGoogle ScholarPubMed
Yarasheski, K, Zachwieja, J & Gisher, J (1998) Increased plasma Gln and Leu R and inappropriately low muscle protein synthesis rate in AIDS wasting. American Journal of Physiology 275, 577–583.Google Scholar